I was watching Face the Nation on Sunday when Shyam Sankar dropped a line that sounded half warning, half taunt. He said some AI people have started smoking to signal faith that AI will cure cancer — and the clip landed like a bell in a room trying to stay calm. You probably scrolled, laughed, and saved the clip for later.
“Like for example, so many AI researchers have started smoking as a way of signaling to other researchers how much they believe in AI. […] ‘I believe so much in AI that it’s going to cure cancer. So I will—I’m showing you my chips are all in.’ So there is kind of this mass psychosis social delusion around it.”
In the CBS studio, Shyam Sankar said it on live TV — why the quip landed as both social critique and meme fodder
I’m not going to pretend Sankar wasn’t baiting a camera. You can hear the mix of exasperation and showmanship when a Palantir CTO offers cultural diagnosis on national television.
He framed the behavior as a symptom: people using visible risk-taking to telegraph belief in AI. That line ricocheted through X/Twitter, where users like @beep1984 joked about lighting up, and others—Mohammed Fayaz Salim among them—claimed they’d relaxed personal health calculus because “AI will fix it in the 2030s.”
Are tech workers really smoking because AI will cure cancer?
Short answer: some say yes, most say no. There are anecdotal pockets where nicotine use and bravado overlap, but the jump from a few founder quotes to a broad behavioral trend is enormous. I watch discourse on platforms like X and Reddit; performative risk signals travel fast, and social proof turns private vice into public statement overnight.
At the coffee shops and Slack channels of Silicon Valley, nicotine chatter is visible — but the context matters
Business Insider ran a piece about a “Silicon Smokers” vibe, and yes, vaping and Zyn pouches are common in tech circles. But prevalence isn’t the same as meaning.
When founders talk about smoking while mentioning “AI will cure it,” that’s signaling, not science. The cigarette becomes less about nicotine and more about identity—like a talisman people wave to show they’ve bet everything on the tech future.
Is smoking making a comeback in Silicon Valley?
There’s a small cultural rebound: some engineers chain-smoke through sprints, some founders flirt with tobacco as a rebellious badge. But the larger change is product-driven—vaping and smokeless nicotine have replaced many traditional cigarettes. Media loves a comeback narrative; communities evolve, and stories exaggerate faster than habits do.
At the margins of hype and attention, founders and reporters amplify each other — and that muddies what’s real
Avi Schiffmann’s offhand line about “AI robots curing lung cancer by the time smokers get sick” blew up because it fit a tidy story: techno-optimism meets self-destruction. Attention is the currency; quotes that are funny or shocking get the most of it.
Counterpoints came fast. AI chatbots like Grok pushed back on the literal reading. Researchers and firms—OpenAI, DeepMind, academic oncology labs—are making measurable progress on models and predictions, but curing cancer is not a single algorithmic flip. Progress is patchwork, noisy, and measured in studies and trials, not tweets.
Will AI cure cancer in the 2030s?
People who say “yes” are betting on sustained funding, regulatory cooperation, and breakthroughs in biology, datasets, and clinical trials. I respect the optimism, but I also track publications, drug pipelines, and regulatory pathways. Expect incremental advances that improve diagnosis and drug discovery, not a cinematic cure-all overnight.
You can file Sankar’s quip under performative signaling or social warning—either way, it tells us something about belief economies in tech; are we watching genuine behavior change or just a very good meme?